Pfizer wins first trial over Zoloft birth-defect claims
The court rejected arguments that Pfizer should be held liable for Logyn Pesantes heart abnormalities19-04-2015
19-04-2015
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Pfizer Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 199216-02-2015
Results Press Release
Pfizer Ltd has submitted to BSE a copy of Results Press Release for the period ended December 31, 2014.14-02-2015
Outcome of Board Meeting
Pfizer Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 14, 2015, has made the following appointments:1. Mr. Sunil Lalbhai has been appointed as an Additional Director (Independent Director) on the Board of the Company with effect from February 14, 2015, subject to the approval of shareholders at the ensuing Annual General Meeting of the Company....14-02-2015
Financial Results & Limited Review for Dec 31, 2014 (Standalone)
Pfizer Ltd has informed BSE about the Standalone Financial Results & a copy of the Limited Review Report for the period ended December 31, 2014.14-02-2015
Closure of Trading Window
Pfizer Ltd has informed BSE that a Meeting of the Board of Directors of the Company is scheduled to be held on February 14, 2015, inter alia, to consider and take on record the Unaudited Financial Results of the Company for the third quarter and nine months ended December 31, 2014.Further, the Trading Window for trading in the Equity shares of the Company will be closed from January 29, 2015 to February 15, 2015, both days inclusive.28-01-2015
Shareholding Pattern as on January 16, 2015
Pfizer Ltd has informed BSE about the Shareholding Pattern as on January 16, 2015.22-01-2015
Shareholding Pattern For December 31, 2014
Pfizer Ltd has informed BSE about the Shareholding Pattern as on December 31, 2014.21-01-2015
Approval for trading of 1,59,06,292 additional shares of Pfizer Ltd
Pfizer Ltd has submitted to BSE a copy of Press Release dated January 12, 2015 titled "Approval for trading of 1,59,06,292 additional shares of Pfizer Ltd"12-01-2015
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Pfizer Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 199222-12-2014